Literature DB >> 31144257

3-Dimensional regional and global strain abnormalities in hypertrophic cardiomyopathy.

Alessandro Satriano1, Bobak Heydari2,3, Namrata Guron1, Kate Fenwick1, Matthew Cheung1, Yoko Mikami1, Naeem Merchant1,4, Carmen P Lydell1,4, Andrew G Howarth1, Nowell M Fine1, James A White1.   

Abstract

Hypertrophic cardiomyopathy (HCM) is characterized by myocardial disarray, hypertrophy, and fibrosis. Reduced global longitudinal strain and presence of late gadolinium enhancement (LGE) by cardiac magnetic resonance imaging (CMR) have been associated with an adverse prognosis. This study evaluated 3D principal and conventional strain characteristics of non-enhanced myocardium in patients with HCM. 3D principal and conventional strain analysis was conducted in 51 HCM patients and 38 healthy controls. Principal strain was reduced within the non-enhanced myocardium of HCM as compared with controls (maximum principal: 51.5 ± 23.7 vs. 75.1 ± 21.4%, P < 0.0001; minimum principal: - 18.4 ± 4.0 vs. - 20.1 ± 2.9%, P < 0.05). Principal strain within the non-enhanced myocardium was incrementally reduced in HCM patients with extensive global LGE ( ≥ 15%) (maximum principal: 41.6 ± 17.5 vs. 56.9 ± 25.9%, P < 0.05; minimum principal: - 16.9 ± 3.9 vs. - 19.1 ± 4.0%, P = 0.1), as was longitudinal ( - 10.5 ± 2.6 vs. - 12.7 ± 2.6%, P < 0.05) and circumferential strain ( - 11.0 ± 2.7 vs. - 14.0 ± 2.9%, P < 0.01). Principal strain within non-enhanced myocardium was significantly correlated with indexed LV mass (P < 0.0001), maximum (P = 0.0008), and mean wall thickness (P < 0.0001), but not LGE (P = 0.0841). In adjusted analysis, all strain measures within non-enhanced myocardium were independently associated with indexed LV mass (maximum principal: P = 0.0003; minimum principal: P = 0.0039; longitudinal: P = 0.0015; circumferential: P = 0.0002; radial: P = 0.0023). 3D principal strain of non-enhanced myocardium was significantly reduced in HCM patients as compared with controls, and was incrementally reduced among patients with more extensive global LGE. Comprehensive strain assessment may be considered in routine CMR assessment of HCM patients.

Entities:  

Keywords:  Cardiomyopathy; Contractile function; Hypertrophy; Magnetic resonance imaging

Mesh:

Substances:

Year:  2019        PMID: 31144257     DOI: 10.1007/s10554-019-01631-8

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  18 in total

Review 1.  Myocardial tagging by cardiovascular magnetic resonance: evolution of techniques--pulse sequences, analysis algorithms, and applications.

Authors:  El-Sayed H Ibrahim
Journal:  J Cardiovasc Magn Reson       Date:  2011-07-28       Impact factor: 5.364

2.  Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients.

Authors:  Javier Díez; Ramón Querejeta; Begoña López; Arantxa González; Mariano Larman; José L Martínez Ubago
Journal:  Circulation       Date:  2002-05-28       Impact factor: 29.690

3.  Three-dimensional left ventricular deformation in hypertrophic cardiomyopathy.

Authors:  A A Young; C M Kramer; V A Ferrari; L Axel; N Reichek
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

4.  T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.

Authors:  Carolyn Y Ho; Siddique A Abbasi; Tomas G Neilan; Ravi V Shah; Yucheng Chen; Bobak Heydari; Allison L Cirino; Neal K Lakdawala; E John Orav; Arantxa González; Begoña López; Javier Díez; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  Circ Cardiovasc Imaging       Date:  2013-04-02       Impact factor: 7.792

5.  Stress hypoperfusion and tissue injury in hypertrophic cardiomyopathy: spatial characterization using high-resolution 3-tesla magnetic resonance imaging.

Authors:  Chung Chun Tyan; Sarah Armstrong; David Scholl; John Stirrat; Kimberly Blackwood; Omar El-Sherif; Terry Thompson; Gerald Wisenberg; Frank S Prato; Aaron So; Ting Yim Lee; Maria Drangova; James A White
Journal:  Circ Cardiovasc Imaging       Date:  2013-02-14       Impact factor: 7.792

6.  Hypertrophy pattern and regional myocardial mechanics are related in septal and apical hypertrophic cardiomyopathy.

Authors:  Hua Yang; Shemy Carasso; Anna Woo; Michal Jamorski; Anna Nikonova; E Douglas Wigle; Harry Rakowski
Journal:  J Am Soc Echocardiogr       Date:  2010-07-21       Impact factor: 5.251

7.  Analysis of three-dimensional endocardial and epicardial strains from cardiac magnetic resonance in healthy subjects and patients with hypertrophic cardiomyopathy.

Authors:  Xiaodan Zhao; Ru San Tan; Hak Chiaw Tang; Shuang Leng; Jun-Mei Zhang; Liang Zhong
Journal:  Med Biol Eng Comput       Date:  2017-07-03       Impact factor: 2.602

8.  Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.

Authors:  Jenifer G Crilley; Ernest A Boehm; Edward Blair; Bheeshma Rajagopalan; Andrew M Blamire; Peter Styles; William J McKenna; Ingegerd Ostman-Smith; Kieran Clarke; Hugh Watkins
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

9.  Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.

Authors:  Andris H Ellims; Leah M Iles; Liang-han Ling; James L Hare; David M Kaye; Andrew J Taylor
Journal:  J Cardiovasc Magn Reson       Date:  2012-10-29       Impact factor: 5.364

Review 10.  Principles of cardiovascular magnetic resonance feature tracking and echocardiographic speckle tracking for informed clinical use.

Authors:  Gianni Pedrizzetti; Piet Claus; Philip J Kilner; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2016-08-26       Impact factor: 5.364

View more
  4 in total

1.  Real-world clinical validity of cardiac magnetic resonance tissue tracking in primitive hypertrophic cardiomyopathy.

Authors:  Pierpaolo Palumbo; Francesco Masedu; Camilla De Cataldo; Ester Cannizzaro; Federico Bruno; Silvia Pradella; Francesco Arrigoni; Marco Valenti; Alessandra Splendiani; Antonio Barile; Andrea Giovagnoni; Carlo Masciocchi; Ernesto Di Cesare
Journal:  Radiol Med       Date:  2021-12-11       Impact factor: 3.469

Review 2.  Strategies for targeting the cardiac sarcomere: avenues for novel drug discovery.

Authors:  Joshua B Holmes; Chang Yoon Doh; Ranganath Mamidi; Jiayang Li; Julian E Stelzer
Journal:  Expert Opin Drug Discov       Date:  2020-02-18       Impact factor: 6.098

Review 3.  Quantification of Myocardial Deformation Applying CMR-Feature-Tracking-All About the Left Ventricle?

Authors:  Torben Lange; Andreas Schuster
Journal:  Curr Heart Fail Rep       Date:  2021-05-01

4.  Causes of altered ventricular mechanics in hypertrophic cardiomyopathy: an in-silico study.

Authors:  Ekaterina Kovacheva; Tobias Gerach; Steffen Schuler; Marco Ochs; Olaf Dössel; Axel Loewe
Journal:  Biomed Eng Online       Date:  2021-07-22       Impact factor: 2.819

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.